GLYXAMBI 25 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
GLYXAMBI 25 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Commercialized
Register Number
1161146014
Prescription Type
Medicamento Sujeto A Prescripción Médica
Authorization Date
Jul 7, 2017
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1161146014
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (2)
EMPAGLIFLOZINAActive
Quantity: 25 mg
Name: EMPAGLIFLOZINA
LINAGLIPTINAActive
Quantity: 5 mg
Name: LINAGLIPTINA
ATC CLASSIFICATION (3)
A10B
A10BD
A10BD19